Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy

Journal of Urology

Volumn 162, Issue 4, 1999, Pages 1337-1340

  Pound, Charles R ^a   Christens Barry, Owen W ^a   Gurganus, Robin T ^a   Partin, Alan W ^a   Walsh, Patrick C ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Digital rectal examination; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RECURRENCE; DIAGNOSTIC IMAGING; FINGER; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATECTOMY; RECTUM;

EID: 0032844009     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68280-8     Document Type: Article

References (17)

1. Trapasso, J. T., DeKernion, J. B., Smith, R. B. and Dorey, F.: The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J. Urol., 152: 1821, 1994.
2. Zinke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P. and Barrett, D. M.: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J. Urol., 152: 1850, 1994.
3. Catalona, W. J. and Smith, D. S.: 5-year recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J. Urol., 152: 1837, 1994.
4. Gerber, G. S., Thisted, R. A., Scardino, P. T., Frohmuller, H. G., Schroeder, F. H., Paulson, D. F., Middleton, A. W., Jr., Rukstalis, D. B., Smith, J. A., Jr., Schellhammer, P. F., Ohori, M. and Chodak, G. W.: Results of radical prostatectomy in men with clinically localized prostate cancer. J.A.M.A., 276: 615, 1996.
5. Baker, L. H., Hanks, G., Gershenson, D., Kantoff, P., Lange, P., Logothetis, C., Sandler, H. and Walsh, P.: NCCN prostate cancer practice guidelines. Oncology, suppl., 10: 265, 1996.
6. Pound, C. R., Partin, A. W., Epstein, J. I. and Walsh, P. C.: Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol. Clin. N. Amer., 24: 395, 1997.
7. Oesterling, J. E.: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907, 1991.
8. Oefelein, M. G., Smith, N., Carter, M., Dalton, D. and Schaeffer, A.: The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J. Urol., 154: 2128, 1995.
9. Hudson, M. A., Bahnson, R. R. and Catalona, W. J.: Clinical use of prostate specific antigen in patients with prostate cancer. J. Urol., 142: 1011, 1989.
10. Goldrath, D. E. and Messing, E. M.: Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy. J. Urol., 142: 1082, 1989.
11. Takayama, T. K., Krieger, J. N., True, L. D. and Lange, P. H.: Recurrent prostate cancer despite undetectable prostate specific antigen. J. Urol., 148: 1541, 1992.
12. Leibman, B. D., Dillioglugil, O., Wheeler, T. M. and Scardino, P. T.: Distant metastasis after radical prostatectomy in patients without and elevated serum prostate specific antigen level. Cancer, 76: 2530, 1995.
13. Partin, A. W., Carter, H. B., Chan, D. W., Epstein, J. I., Oesterling, J. E., Rock, R. C., Weber, J. P. and Walsh, P. C.: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol., 143: 747, 1990.
14. Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, F., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 141: 1076, 1989.
15. Stamey, T. A., Graves, H. C. B., Wehner, N., Ferrari, M. and Freiha, F. S.: Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J. Urol., 149: 787, 1993.
16. Yu, H., Diamandis, E. P., Prestigiacomo, A. F. and Stamey, T. A.: Ultrasensitive assay of prostate specific antigen used for early detection of prostate cancer relapse and estimation of tumor doubling time after radical prostatectomy. Clin. Chem., 41: 430, 1995.
17. Levin, B. and Murphy, G. P.: Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA, 42: 296, 1992.